Skip to main content

MoneyWorks4Me

Morepen Laboratories informs about press release

27 May 2026 Evaluate
Morepen Laboratories has informed that it enclosed press release with the titled, ‘Morepen Labs Q4 Net Profit Rises 69%; CDMO Program Moves into Commercial Execution; Board Proposes a Dividend of 10% to the shareholders for FY26’.

The above information is a part of company’s filings submitted to BSE. 
Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1371.20
Cipla 1409.00
Lupin 1990.00
Zydus Lifesciences 1195.00
View more..